Is Histogen Inc (HSTO) a Loser in the Healthcare Sector?

Friday, April 14, 2023 12:09 PM | InvestorsObserver Analysts

Mentioned in this article

Is Histogen Inc (HSTO) a Loser in the Healthcare Sector?

Histogen Inc (HSTO) is around the bottom of the Healthcare sector according to InvestorsObserver. HSTO received an overall rating of 39, which means that it scores higher than 39% of stocks. Additionally, Histogen Inc scored a 21 in the Healthcare sector, ranking it higher than 21% of stocks in that sector.

HSTO has an Overall Score of 39. Find out what this means to you and get the rest of the rankings on HSTO!

See Full HSTO Report

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 39 means the stock is more attractive than 39 percent of stocks. This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in the healthcare sector with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With Histogen Inc Stock Today?

Histogen Inc (HSTO) stock has gained 4% while the S&P 500 is lower by -0.41% as of 11:49 AM on Friday, Apr 14. HSTO is higher by $0.04 from the previous closing price of $1.00 on volume of 10,402 shares. Over the past year the S&P 500 is down -5.99% while HSTO is lower by -78.95%. HSTO lost -$3.46 per share the over the last 12 months. Click Here to get the full Stock Report for Histogen Inc stock.